P508 Evaluation of the diagnostic performance of two commercially available tests for infliximab trough levels (IFX-TL) and antibodies to infliximab (ATI) titration in inflammatory bowel disease (IBD)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.